Compared to the control group, the METTL14 knockdown group exhibited significantly reduced tumour volume (Figure 2F) and weight (Figure 2G), while overexpression of METTL14 promoted the growth of the xenograft tumours (Figure 2E‐G). The gene discussed is METTL14; the disease is neoplasm.